# Jiangxi Synergy Pharmaceutical, Co., Ltd., Yichun, China – FDA Inspections

Source: https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5

> Inspection records and compliance data for Jiangxi Synergy Pharmaceutical, Co., Ltd. in Yichun. 5 FDA inspections on record, 1 Form 483, last inspected August 07, 2025.

---

## Details

- Name: Jiangxi Synergy Pharmaceutical, Co., Ltd.
- FEI Number: 3008465739
- Business Operations: API MANUFACTURE
- Address Line 1: Jiangxi Fengxin Industrial Park, 699 Changle Avenue
- City: Yichun
- Country Name: China
- Address: Jiangxi Fengxin Industrial Park, 699 Changle Avenue, Yichun, China
- Country: China

## Related Documents

- FDA Inspection 1280670 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2025-08-07 — source: FDA, date: August 7, 2025
- [FDA Inspection 1280670 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2025-08-07](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/7c7ba0ec-52be-431b-9d4f-87e4436eaee3) — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2025
- [483 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2019-01-10](https://www.keypedia.com/records/483/jiangxi-synergy-pharmaceutical-co-ltd/593f05b9-a0ab-4103-adf1-cf723591f6e9) — source: FDA, date: January 10, 2019
- [FDA Inspection 1078075 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2019-01-10](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/860afe5f-1f7c-4561-9a5d-fb6d947ffb81) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 10, 2019
- [FDA Inspection 996538 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2016-09-09](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/b8e66a8e-136e-49ea-ac40-542f530683f8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- FDA Inspection 881487 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2014-05-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2014
- [FDA Inspection 614643 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2009-09-11](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/bf561fc6-636e-4543-b625-bfb671b1bb46) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2009

## Related Companies

- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)

## Related Officers

- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)